Back The PCCS, alongside a number of other societies and associations across the UK, has come together to provide guidance on the safe switching of warfarin to DOACs

This needs to be undertaken in a phased manner over the 12-week cycle of INR monitoring to protect the supply chain for ALL patients. As highlighted, many patients are not suitable for a switch from warfarin to DOACs and further guidance will be available

shortly to support services providing care for these patients. Further information here.